Ipilimumab/nivolumabVarious toxicities: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1771卷 / 1期

关键词：

D O I：

10.1007/s40278-019-67999-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：180 / 180

相关论文

共 50 条

[31] Avelumab/ipilimumab/nivolumabVarious toxicities: 7 case reports
Reactions Weekly, 2021, 1837 (1) : 88 - 88
[32] Denosumab/ipilimumab/nivolumabVarious toxicities: 4 case reports
Reactions Weekly, 2019, 1763 (1) : 133 - 133
[33] Avelumab/ipilimumab/nivolumabVarious toxicities: 3 case reports
Reactions Weekly, 2023, 1981 (1) : 75 - 75
[34] Axicabtagene-ciloleucel/ipilimumab/nivolumabVarious toxicities: 2 case reports
Reactions Weekly, 2021, 1854 (1) : 71 - 71
[35] Ipilimumab/nivolumabVarious toxicities and lack of efficacy: 24 case reports
Reactions Weekly, 2024, 2024 (1) : 244 - 244
[36] Ipilimumab/nivolumabVarious toxicities and lack of efficacy: 6 case reports
Reactions Weekly, 2022, 1924 (1) : 260 - 260
[37] Ipilimumab/nivolumabVarious toxicities: 2 case report
Reactions Weekly, 2016, 1632 (1) : 172 - 172
[38] NivolumabVarious toxicities: 2 case reports
Reactions Weekly, 2017, 1654 (1) : 259 - 259
[39] NivolumabVarious toxicities: 2 case reports
Reactions Weekly, 2018, 1683 (1) : 521 - 521
[40] NivolumabVarious toxicities: 2 case reports
Reactions Weekly, 2017, 1681 (1) : 271 - 271

← 1 2 3 4 5 →